Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 7151285, 9 pages
https://doi.org/10.1155/2017/7151285
Research Article

Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris

Laboratory of Immunology, Federal University of Triângulo Mineiro, Uberaba, MG, Brazil

Correspondence should be addressed to Carlo Jose Freire Oliveira; rb.ude.mtfu.nbci@olrac

Received 24 October 2016; Revised 17 January 2017; Accepted 1 February 2017; Published 22 February 2017

Academic Editor: Vincenzo Brancaleone

Copyright © 2017 Rodolfo Pessato Timoteo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. W. Yeh, N. Sami, and R. A. Ahmed, “Treatment of pemphigus vulgaris: current and emerging options,” American Journal of Clinical Dermatology, vol. 6, no. 5, pp. 327–342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Pisanti, Y. Sharav, E. Kaufman, and L. N. Posner, “Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 38, no. 3, pp. 382–387, 1974. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Echigo, M. Hasegawa, Y. Shimada, M. Inaoki, K. Takehara, and S. Sato, “Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases,” Archives of Dermatological Research, vol. 298, no. 1, pp. 38–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Nakashima, M. Fujimoto, N. Asashima et al., “Serum chemokine profile in patients with bullous pemphigoid,” British Journal of Dermatology, vol. 156, no. 3, pp. 454–459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. N. Giordano and A. A. Sinha, “Cytokine networks in Pemphigus vulgaris: an integrated viewpoint,” Autoimmunity, vol. 45, no. 6, pp. 427–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Giurdanella, L. Fania, M. Gnarra et al., “A possible role for CD8+ T lymphocytes in the cell-mediated pathogenesis of pemphigus vulgaris,” Mediators of Inflammation, vol. 2013, Article ID 764290, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Satyam, S. Khandpur, V. K. Sharma, and A. Sharma, “Involvement of TH1/TH2 cytokines in the pathogenesis of autoimmune skin disease—pemphigus vulgaris,” Immunological Investigations, vol. 38, no. 6, pp. 498–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. D'Auria, C. Bonifati, A. Mussi et al., “Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity,” European Cytokine Network, vol. 8, no. 4, pp. 383–387, 1997. View at Google Scholar · View at Scopus
  9. F. Ameglio, L. D'Auria, P. Cordiali-Fei et al., “Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age,” Journal of Biological Regulators and Homeostatic Agents, vol. 13, no. 4, pp. 220–224, 1999. View at Google Scholar · View at Scopus
  10. L. D'Auria, C. Bonifati, P. Cordiali-Fei et al., “Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity,” Archives of Dermatological Research, vol. 291, no. 6, pp. 354–356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. D. B. Keskin, J. N. H. Stern, M. Fridkis-Hareli, and A. Razzaque Ahmed, “Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy,” Cytokine, vol. 41, no. 3, pp. 315–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. J. Ludwig and E. Schmidt, “Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis?” Giornale Italiano di Dermatologia e Venereologia, vol. 144, no. 4, pp. 339–349, 2009. View at Google Scholar · View at Scopus
  13. J. Narbutt, J. Lukamowicz, J. Bogaczewicz, A. Sysa-Jedrzejowska, J. D. Torzecka, and A. Lesiak, “Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris,” Mediators of Inflammation, vol. 2008, Article ID 875394, 5 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ragab, M. Abdallah, E. El-Gohary, and R. Elewa, “Stress and serum TNF-α levels may predict disease outcome in patients with pemphigus: a preliminary study,” Cutis, vol. 87, no. 4, pp. 189–194, 2011. View at Google Scholar · View at Scopus
  15. H. Mortazavi, N. Esmaili, S. Khezri et al., “The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients,” Iranian Journal of Allergy, Asthma and Immunology, vol. 13, no. 3, pp. 174–183, 2014. View at Google Scholar · View at Scopus
  16. K. C. Bhol, A. I. Rojas, I. U. Khan, and A. R. Ahmed, “Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid,” Cytokine, vol. 12, no. 7, pp. 1076–1083, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Baroni, B. Perfetto, E. Ruocco, R. Greco, D. Criscuolo, and V. Ruocco, “Cytokine pattern in blister fluid and sera of patients with pemphigus,” Dermatology, vol. 205, no. 2, pp. 116–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Xue, W. Su, Z. Chen, Y. Ke, X. Du, and Q. Zhou, “Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study,” Mediators of Inflammation, vol. 2014, Article ID 463928, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hettiaratchy and R. Papini, “Initial management of a major burn: II—assessment and resuscitation,” British Medical Journal, vol. 329, no. 7457, pp. 101–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Aoki, E. A. Rivitti, and L. A. Diaz, “Update on fogo selvagem, an endemic form of pemphigus foliaceus,” Journal of Dermatology, vol. 42, no. 1, pp. 18–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Cho, C. T. Ellebrecht, and A. S. Payne, “The dual nature of interleukin-10 in pemphigus vulgaris,” Cytokine, vol. 73, no. 2, pp. 335–341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Tanaka, M. Komai, K. Nagao et al., “Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 1, pp. 62–68, 2004. View at Publisher · View at Google Scholar · View at Scopus